Clinical Trial Update: Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FX006 in Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adhesive Capsulitis
• Osteoarthritis of the Shoulder

Drugs mentioned

• FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Shoulder, Adhesive Capsulitis | Phase 2 | Status: TERMINATED | Results posted: 2021-11-30